Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Personalized Medicine and Personalized Pricing: Degrees of Price Discrimination (CROSBI ID 64591)

Prilog u knjizi | izvorni znanstveni rad | međunarodna recenzija

Mance, Davor ; Mance, Diana ; Vitezić, Dinko Personalized Medicine and Personalized Pricing: Degrees of Price Discrimination // Personalized Medicine in Healthcare Systems Legal, Medical and Economic Implications / Bodiroga-Vukobrat, Nada ; Rukavina, Daniel ; Pavelić, Krešimir et al. (ur.). Cham: Springer, 2019. str. 171-180 doi: 10.1007/978-3-030-16465-2_14

Podaci o odgovornosti

Mance, Davor ; Mance, Diana ; Vitezić, Dinko

engleski

Personalized Medicine and Personalized Pricing: Degrees of Price Discrimination

Economics developed a set of three degrees of price discrimination dependent on whether the seller targets individuals or groups, and whether buyers wish to use quantity rebates. The seller’s reason to price discriminate is to capture as much of the buyers utility surplus. Price discrimination is deemed unfair and immoral, and this is especially so in the market for pharmaceutical therapies. However, sometimes it can indeed be socially useful to price discriminate as the practice, under circumstances, enhances efficiency and social welfare. The market for pharmaceuticals is a non-typical market as irreversible costs of research and development form the brunt of the cost structure. As pharmaceutical companies are driven by profit and bounded by patent expiration dates, discriminatory pricing schemes are necessary to recover investment costs of research and development as quickly as possible. The first degree of price discrimination consists of perfect, individually targeted, price/quality combinations that fully extract consumers’ surplus. The second-degree price discrimination consists of quantity rebates. The third degree of price discrimination is based on group targeting according to the group average willingness to pay. We introduce a fourth degree of price discrimination based on qualitative features of pharmaceuticals on a market for antiviral drugs. We use the SVR as an example of quality differentials causing market price differentials. The fourth type of discrimination would be of particular interest to the pharmaceutical industry and health management organisations as it introduces non-linear price- quality combinations.

personalized medicine, personalized pricing, price discrimination

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

171-180.

objavljeno

10.1007/978-3-030-16465-2_14

Podaci o knjizi

Personalized Medicine in Healthcare Systems Legal, Medical and Economic Implications

Bodiroga-Vukobrat, Nada ; Rukavina, Daniel ; Pavelić, Krešimir ; Sander, Gerald G.

Cham: Springer

2019.

978-3-030-16464-5

2366-0953

2366-0961

Povezanost rada

Ekonomija, Interdisciplinarne prirodne znanosti, Temeljne medicinske znanosti

Poveznice
Indeksiranost